{"id":"https://openalex.org/W1996580481","doi":"https://doi.org/10.1055/s-2006-949655","title":"Starting Insulin Therapy in Type 2 Diabetes: Twice-Daily Biphasic Insulin Aspart 30 Plus Metformin versus Once-Daily Insulin Glargine Plus Glimepiride","display_name":"Starting Insulin Therapy in Type 2 Diabetes: Twice-Daily Biphasic Insulin Aspart 30 Plus Metformin versus Once-Daily Insulin Glargine Plus Glimepiride","alternate_titles":[],"publication_year":2006,"publication_date":"2006-11-17","ids":{"openalex":"https://openalex.org/W1996580481","doi":"https://doi.org/10.1055/s-2006-949655","mag":"1996580481","pmid":"https://pubmed.ncbi.nlm.nih.gov/17115351"},"language":"en","primary_location":{"id":"doi:10.1055/s-2006-949655","doi":"https://doi.org/10.1055/s-2006-949655","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2006-949655","pdf_url":null,"source":{"id":"https://openalex.org/S67343978","display_name":"Experimental and Clinical Endocrinology & Diabetes","issn_l":"0947-7349","issn":["0947-7349","1439-3646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Endocrinology &amp; Diabetes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1996580481"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021928949","display_name":"PH Kann","orcid":"https://orcid.org/0009-0000-3451-8754","observed_orcids":["https://orcid.org/0009-0000-3451-8754"]},"institutions":[{"id":"https://openalex.org/I161103922","display_name":"Philipps University of Marburg","ror":"https://ror.org/01rdrb571","country_code":"DE","type":"education","lineage":["https://openalex.org/I161103922"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Kann","raw_affiliation_strings":["Philipps-Universit\u00e4t Marburg, Zentrum f\u00fcr Innere Medizin, Bereich Endokrinologie and Diabetologie, Marburg, Germany. kannp@med.uni-marburg.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Philipps-Universit\u00e4t Marburg, Zentrum f\u00fcr Innere Medizin, Bereich Endokrinologie and Diabetologie, Marburg, Germany. kannp@med.uni-marburg.de","institution_ids":["https://openalex.org/I161103922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110028723","display_name":"Thomas C. Wascher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T. Wascher","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"V. Zackova","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"V. Zackova","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057122339","display_name":"Johannes Moeller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Moeller","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005019347","display_name":"J Medding","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Medding","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041482664","display_name":"Albert Sz\u00f6cs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A. Szocs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021414260","display_name":"Marian Mok\u00e1\u0148","orcid":"https://orcid.org/0000-0002-9674-1799","observed_orcids":["https://orcid.org/0000-0002-9674-1799"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Mokan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002068967","display_name":"Franc Mrevlje","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Mrevlje","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5110638795","display_name":"Mateusz Regulski","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Regulski","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.6654,"has_fulltext":false,"cited_by_count":116,"citation_normalized_percentile":{"value":0.97292114,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"114","issue":"09","first_page":"527","last_page":"532"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.023600000888109207,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8539999723434448},{"id":"https://openalex.org/keywords/insulin-initiation","display_name":"insulin initiation","score":0.8259999752044678},{"id":"https://openalex.org/keywords/biphasic-insulin-aspart-30","display_name":"biphasic insulin aspart 30","score":0.9319999814033508},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.8799999952316284},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9700000286102295},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9869999885559082},{"id":"https://openalex.org/keywords/insulin-naive-patients","display_name":"insulin-naive patients","score":0.7860000133514404},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9309999942779541},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9449999928474426},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.9490000009536743},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.7979999780654907},{"id":"https://openalex.org/keywords/insulin-dose","display_name":"insulin dose","score":0.6060000061988831},{"id":"https://openalex.org/keywords/insulin-analogs","display_name":"insulin analogues","score":0.5609999895095825},{"id":"https://openalex.org/keywords/multiple-daily-injections","display_name":"multiple daily insulin injections","score":0.6190000176429749},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.7879999876022339}],"concepts":[{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.8837096691131592},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8542110919952393},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7788249850273132},{"id":"https://openalex.org/C2779908123","wikidata":"https://www.wikidata.org/wiki/Q2754775","display_name":"Insulin aspart","level":4,"score":0.7656607627868652},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.7106602787971497},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.6632466912269592},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.6305233836174011},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5194158554077148},{"id":"https://openalex.org/C2779920387","wikidata":"https://www.wikidata.org/wiki/Q417317","display_name":"Insulin glargine","level":4,"score":0.506648600101471},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4486366808414459},{"id":"https://openalex.org/C2780668416","wikidata":"https://www.wikidata.org/wiki/Q202758","display_name":"Hypoglycemia","level":3,"score":0.4163685441017151}],"mesh":[{"descriptor_ui":"D000069036","descriptor_name":"Insulin Glargine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D007336","descriptor_name":"Insulin, Isophane","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D008687","descriptor_name":"Metformin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013453","descriptor_name":"Sulfonylurea Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049528","descriptor_name":"Insulin, Long-Acting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061265","descriptor_name":"Biphasic Insulins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061267","descriptor_name":"Insulin Aspart","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1055/s-2006-949655","doi":"https://doi.org/10.1055/s-2006-949655","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2006-949655","pdf_url":null,"source":{"id":"https://openalex.org/S67343978","display_name":"Experimental and Clinical Endocrinology & Diabetes","issn_l":"0947-7349","issn":["0947-7349","1439-3646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Clinical Endocrinology &amp; Diabetes","raw_type":"journal-article"},{"id":"pmid:17115351","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17115351","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320322436","display_name":"Novo Nordisk","ror":"https://ror.org/0435rc536"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1990924858","https://openalex.org/W2114369760","https://openalex.org/W2388217144","https://openalex.org/W1977962529","https://openalex.org/W2588043301","https://openalex.org/W2001387623","https://openalex.org/W2011070839","https://openalex.org/W2098898873","https://openalex.org/W4231659820","https://openalex.org/W1997698566"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"compare":[2],"the":[3,92,115,122,160,183],"efficacy":[4],"and":[5,34,71,80,174,188,207,264],"safety":[6],"of":[7,105,176,219,234],"two":[8],"analog":[9],"insulins":[10],"as":[11],"starting":[12],"regimens":[13],"in":[14,54,94,97,114,170,182,249],"insulin-na\u00efve":[15,56],"Type":[16,250],"2":[17,251],"diabetes":[18,252],"patients.":[19],"METHODS:":[20],"In":[21],"this":[22],"randomized,":[23],"open-label":[24],"parallel":[25],"study,":[26],"twice-daily":[27,255],"biphasic":[28],"insulin":[29,37,48,200,248],"aspart":[30],"30":[31,75,117,145,185,206,231,257],"(30%":[32],"soluble":[33],"70%":[35],"protaminated":[36],"aspart;":[38],"BIAsp":[39,74,116,144,184,205,230,256],"30)":[40],"plus":[41,51,76,82,118,124,146,151,186,190,212,232,258,277],"metformin":[42],"(met)":[43],"was":[44,69,91,111,140,237],"compared":[45,148],"with":[46,149,229,254],"once-daily":[47,275],"glargine":[49],"(glarg)":[50],"glimepiride":[52],"(glim)":[53],"255":[55],"patients":[57,177,214,253],"(131":[58],"male;":[59],"mean+/-SD":[60],"age,":[61],"61.2+/-9.1":[62],"years).":[63],"Mean":[64,135],"baseline":[65],"HbA":[66,98,108,262],"(1c)":[67,99,109,263],"(+/-SD)":[68],"9.2+/-1.4%":[70],"8.9+/-1.3%":[72],"for":[73,143],"met":[77,119,147,187,233,259],"(":[78,84,87,194],"N=128)":[79],"glarg":[81,123,150,189,276],"glim":[83,125,191],"N=127),":[85],"respectively":[86,193],"P=0.0747).":[88],"Primary":[89],"endpoint":[90],"difference":[93],"absolute":[95],"change":[96,110,228],"between":[100],"groups":[101],"after":[102],"26":[103],"weeks":[104],"treatment.":[106],"RESULTS:":[107],"significantly":[112,141],"greater":[113,272],"group":[120,126],"than":[121,274],"(between-group":[127],"difference:":[128],"-0.5%":[129],"(95%":[130,222,241],"CI:":[131,223,242],"-0.8;":[132],"-0.2);":[133],"P=0.0002).":[134],"prandial":[136,266],"plasma":[137,267],"glucose":[138,268],"increment":[139,269],"lower":[142],"glim:":[152],"1.4+/-1.4":[153],"mmol/l":[154],"vs.":[155],"2.2+/-1.8":[156],"mmol/l;":[157],"P=0.0002.":[158],"During":[159],"maintenance":[161],"phase":[162],"(weeks":[163],"6-26),":[164],"one":[165],"major":[166],"hypoglycemic":[167,180],"episode":[168],"occurred":[169],"each":[171],"group;":[172],"20.3%":[173],"9%":[175],"experienced":[178,215],"minor":[179],"episodes":[181],"groups,":[192],"P=0.0124).":[195],"At":[196],"end-of-trial,":[197],"mean":[198,265],"daily":[199],"doses":[201],"were":[202],"0.40":[203],"U/kg":[204,209],"0.39":[208],"glarg.":[210],"Glarg":[211],"glim-treated":[213],"significant":[216,240],"weight":[217],"gain":[218],"1.5":[220],"kg":[221,236],"0.84;":[224],"2.19;":[225],"P<0.0001).":[226],"Weight":[227],"+0.7":[235],"not":[238],"statistically":[239],"-0.07;":[243],"1.42;":[244],"P=0.0762).":[245],"CONCLUSIONS:":[246],"Starting":[247],"can":[260],"reduce":[261],"to":[270],"a":[271],"extent":[273],"glim.":[278]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1996580481","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":8}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
